Female drinking, environment and biological markers

Annali dell'Istituto Superiore di Sanita

Volumn 42, Issue 1, 2006, Pages 31-38

  Mancinelli, Rosanna ^a   Binetti, Roberto ^a   Ceccanti, Mauro ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Alcohol; Biomarker; Environment; Gender; Prenatal exposure; Woman

Indexed keywords

BIOLOGICAL MARKER;

ALCOHOL ABUSE; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; ALCOHOLISM; COST; DRINKING BEHAVIOR; ENVIRONMENTAL FACTOR; HEALTH STATUS; HUMAN; PREGNANCY; PRENATAL EXPOSURE; PUBLIC HEALTH; REVIEW; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGING; ALCOHOL DRINKING; BIOLOGICAL MARKERS; ENVIRONMENT; FEMALE; HUMANS; PREGNANCY;

EID: 33746842761     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Meyerhoff DJ, Bode C, Nixon SJ, de Bruin EA, Bode JC, Seitz HK. Health risks of cronic moderate and heavy alcohol consumption: how much is too much? Alcohol Clin Exp Res 2005;29(7):1334-40.
2. Mancinelli R, Guiducci MS. La donna e l'alcol: vulnerabilità biologica? Ann Ist Super Sanità 2004;40(1):19-23.
3. National Institute on Alcohol and Alcohol Abuse (NIAAA). Alcohol and woman. Bethesda: NIAAA; 1990 (Alcohol Alert n. 10: PH 290).
4. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Huges M. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the USA: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
5. Substance Abuse and Mental Health Services Administration. Summary of findings from the 1999 National Household Survey on Drug Abuse. Rockville: US Department of Health and Human Services; 2000.
6. European Monitoring Centre for Drugs and Drug Addiction. Male and female drug use: is the gap narrowing? Lisbona: EMCDDA; 2005 (Dragnet Europe Issue 50 April-June 2005).
7. Warren KR, Foudin LL. Alcohol related birth defects, the past, present and future. Alcohol Res Health 2001;25(3):153-8.
8. Lanphear BP and Bearer CF. Biomarkers in paediatric research and practice. Arch Dis Child 2005;90:594-600.
9. Sasso GF, Mancinelli R, Attilia ML, Cavalieri G, Balducci G, Ceccanti M. Markers biologici dell'abuse alcolico. Roma: Edizioni SITAC; 2004.
10. Lieber CS. Metabolism of alcohol. Clin Liver Dis 2005;9(1):1-35.
11. Lieber CS. New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments. Curr Gastroenterol Rep 2004 Feb;6(1):60-5.
12. Ely M, Hardy R, Longford NT, Wadsworth MEJ. Gender differences in the relationship between alcohol consumption and drink problems are largely account for body water. Alcohol Alcohol 1999;34(6)894-902.
13. Goist K, Sutker P. Acute alcohol intoxication and body composition in women and men. Pharmacol Biochem Behav 1985;22(2):811-4.
14. Frezza M, Di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first pass metabolism. N Engl J Med 1990;322:95-9.
15. Baraona E, Abittan CS, Dohmen K, Moretti M, Pozzato G, Chayes ZW, Shaefer C, Lieber CS. Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res 2001;25(4):502-7.
16. Parlesak A, Billinger MHU, Bode C, Bode JC. Gastric alcohol dehydrogenase activity in man influence of gender, age, alcohol consumption and smoking in a Caucasian population. Alcohol Alcohol 2002;37(4):388-93.
17. Maruff P, Falleti MG, Collie A, Darby D, Mc Stephen M. Fatigue-related impairment in the speed, accuracy and variability of psychomotor performance:comparison with blood alcohol levels. J Sleep Res 2005;14(1):21-7.
18. Lammers SM. Do alcohol pharmacokinetics in women vary due to the menstrual cycle? Addiction 1995;90(1):23-30.
19. Day CP. Who gets alcoholic liver disease: nature or nurture? JR Coll Physicians Lond 2000;24:557-62.
20. Konno A, Enomoto N, Takei Y, Hirose M, Ikejma K, Sato N. Oral contraceptives worsen endotoxin induced liver injury in rats. Alcohol Clin Exp Res 2002;26(8):70S-74S.
21. Eggert J, Theobald H, Engfeldt P. Effects of alcohol consumption on female fertility during an 18-year period. Fertil Steril 2004;81(2):379-83.
22. Dumitrescu RG, Shields PG. The etiology of alcohol-induced breast cancer. Alcohol 2005;35:213-25.
23. Suzuki R, Ye W, Rylander-Rudqvist T, Saji S, Colditz GA, Wolk A. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study. J Natl Cancer Inst 2005;2;97(21):1601-8.
24. Onland-Moret NC, Peeters PH, van der Schow YT, Grobbeee DF, van Gils CH. Alcohol and endogenous sex steroid levels in postmenopausal women: a cross sectional study. J Clin Endocrinol Metab 2005;90(3):1414-9.
25. US Department of Health and Human Services, NHI, NIAAA. Alcohol - an important womens health issue. Bethesda: NIAAA; 2004 (Alcohol Alert n. 62, July 2004).
26. De Bellis MD, Clark DB, Beers SR, Soloff PH, Boring AM, Hall J, Kersh A, Keshavan MS. Hippocampal volume in adolescent-onset alcohol use disorders. Am J Psychiatry 2000;157(5):737-44.
27. Hommer D, Momenan R, Kaiser E, Rawlings R. Evidence for a gender-related effects of alcoholism on brain volumers. Am J Psychiatry 2001;158(2):198-204.
28. Ge X, Conger RD, Elder GH Jr. Pubertal transition, stressful life events, and the emergence of gender differences in adolescence depressive symptoms. Dev Psychol 2001;37(3):404-17.
29. Vik P, Brown SA. Life events and substance abuse during adolescence. In: Miller TW (Ed.) Children of trauma. Madison, CT: International Universities Press;1998.pp179-204.
30. Wagner EF. Delay of gratification, coping with stress and substance use in adolescence. Exp Clin Psycopharmacol 1993;1:27-43.
31. Silveri MM, Spear LP. Decrease sensitivity to the hypnotic effects of ethanol early in ontogeny. Alcohol Clin Exp Res 1998;22:670-6.
32. Markwiese BJ, Acheson SK, Levin ED, Wilson WA, Swartzwelder HS. Differential effects of ethanol on memory in adolescent and adult rats. Alcohol Clin Exp Res 1998;22:416-21.
33. Grant BF. The impact of a family history of alcoholism on the relationship between age at onset of alcohol use and DSM-IV alcohol dependence: Results of the National Longitudinal Alcohol Epidemiologic Survey. Alcohol Health Res World 1998;22:144-7.
34. Emanuele N, Emanuele MA. Alcohol alters critical hormonal balance. Alcohol Health Res World 1997;21(1):53-64.
35. Mello NK, Mendelson JH, Teoh SK. Overview of the effects of alcohol on the neuroendocrine function in women. In: Zakhari, S (Ed.) Alcohol and the endocrine system. Bethesda: NIAAA; 1993 (National Institute on Alcohol Abuse and Alcoholism Research Monograph No.23.NIH Pub. No.93-3533: pp.139-69).
36. Riley EP, Mattson SN, Li TK, Jacobson SW, Coles CD, Kodituwakku PW, Adnams CM, Korkman MI. Neurobehavioral consequences of prenatal alcohol exposure: an international perspective. Alcohol Clin Exp Res 2003;27(2):362-73.
37. Department of Health and Human Services, Public Health Service. Surgeon General's advisory on alcohol and pregnancy. Washington: FDA;1981. FDA Drug Bullettin 11(2):9-10.
38. Vachon CM, Cerchan JR, Vierkant RA, Sellers TA. Investigation of an interaction of alcohol intake and family history on breast cancer risk in the Minnesota Breast Cancer Family Study. Cancer 2001;92(2):240-8.
39. Dorgan JF, Baer DJ, Albert PS, Judd JT, Brown ED, Corle DK, Campbell WS, Hartman TJ, Tejpar AA, Clevidence BA, Giffen CA, Chandler DW, Stanczyk FZ, Taylor PR. Serum hormones and the alcohol-breast cancer association in postmenopausal women. J Natl Cancer Inst 2001;93:710-51.
40. Nelson HD, Humphtey LL, Nygren P, et al. Postmenopausal hormone replacement therapy: Scientific review. JAMA 2002;288:872-81.
41. Register TC, Cline JM, and Shively CA. Health issues in postmenopausal women who drink. Alcohol Res Health 2002;26(4)299-307.
42. National Institutes of Health Osteoporosis and Related Bone Disease-National Resource Center. Osteoporosis Overview. Washington: NIH ORBD NC DC; 1999.
43. Edelson OW, Kleerekoper M. Bone mass, bone loss, and fractures. In: Matkovic V (Ed.) Physical Medicine and Rehabilitation Clinics of North America. Philadelphia: WB Saunders;1995, pp 455-64.
44. Bonnivk SL. The Osteoporosis Handbook. Dallas: Taylor Publishing; 1994.
45. Hansen MA, Overgaard K, Rus BJ, Christiansen C. Potential risk factors for development of postmenopausal osteoporosis-Examined over a 12 years period. Osteopor Int 1991;1(2):95-102.
46. Felson DT, Zhang YQ, Hannan MT, Kannel WB, Kiel DP. Alcohol intake and bone mineral density in elderly men and women- The Framingham Study. Am J Epidemiol 1995;142:485-92.
47. Sampson HW. Alcohol and other factors affecting Osteoporosis risk in women. Alcohol Res Health 2002;26(4):292-98.
48. Deng HW, Cheng WM, Conway T, Zhou Y, Davies KM, Stegman MR, Deng H, Recker RR. Determination of bone mineral density of the hip and spine in human pedigrees by genetic and life-style factors. Genet Epidemiol 2000;19:160-77.
49. Sohrabji F. Neurodegeneration in women. Alcohol Res Health 2003;26(4):316-18.
50. Lieber CS. Biochemical factors in alcoholic liver disease. Semin Liver Dis 1993;13(2):136-53.
51. Campbell JD. Lifestyle, minerals and health. Med Hypoptheses 2001;57(5):521-31.
52. Bellinger D, Leviton A, Sloman J. Antecedents and correlates of improved cognitive performance in children exposed in utero to low level of lead. Environ Health Perspect 1990;89:5-11.
53. Dietrich KN, Berger OG, Succop PA, Hammond PB, Bornschein RL. The developmental consequences of low to moderate prenatal and postnatal lead exposure. Intellectual attainment in the Cincinnati Lead Study Cohort following school entry. Neurotoxicol Teratol 1993;15(1):37-44.
54. Opler MG, Susser ES. Fetal environment and schizophrenia. Environ Health Perspect 2005;113(9):1239-42.
55. Needleman HL, Schell A, Bellinger D, Leviton A, Allred EN. The long term effects of exposure to low doses of lead in childhood. An 11-years follow up report. N Engl J Med 1990;322:83-8.
56. Dietrich K, Ris M, Succop et al. Early exposure to lead and juvenile delinquency. Neurotox Teratol 2001;23:511-18.
57. Ceccanti M, Mancinelli R, Sasso GF, Allen JP, Binetti R, Mellini A, Attilia F, Toppo L, Attilia ML. Erythrocyte thiamine (Th) esters: a major factor of the alcohol withdrawal syndrome or a candidate marker for alcoholism itself? Alcohol Alcohol 2005;40(4):283-90.
58. Flora SJ, Kumar D, Sachan SR, Das Gupta S. Combined exposure to lead and ethanol on tissue concentration of essential metals and some biochemical indices in rat. Biol Trace Elem Res 1991;28(2):157-64.
59. Grilo Reina A, Lopez Artiguez M, Castilla L, Castro M, Garcia-Bragado F, Repetto M. Wine as source of lead contamination. Study in southern region of Seville. Med Clin (Barc) 1990;95(8):281-5.
60. Brooks PJ, Theruvathu JA. DNA adducts from acetaldehyde: implications for alcohol-related carcinogenesis. Alcohol 2005;35(3):187-93.
61. Theruvathu JA, Jaruga P, Nath RG, Dizdaroglu M, Brooks PJ. Polyamines stimulate the formation of mutagenic 1,N2-propanodeoxyguanosine adducts from acetaldehyde Nucleic Acid Res 2005;33(11):3513-20.
62. Pan J, Chung FL. Formation of cyclic deoxyguanosine adducts from omega-3 and omega-6 polyinsaturated fatty acids under oxidative conditions. Chem Res Toxicol 2002;15:367-72.
63. Eder E, Budiawan. Cancer risk assessment for the environmental mutagen and carcinogen crotonaldehyde on the basis of TD50 and comparison with 1,N2-propanodeoxyguanosine adduct levels. Cancer Epidemiol Biomarkers Prev 2001;10:883-8.
64. Nath JE, Ocando JB, Guttenplan F, Chung L. 1,N2-propanodeoxyguanosine adducts: potential new markers of smoking induced DNA damage in human oral tissue. Cancer Res 1998;58:581-4.
65. Schwan R, Ibuisson E, Malet L, Loiseaux MN, Reynaud M, Schellenberg F, Brousse G, Llorca PM. The use of biological laboratory markers in the diagnosis of alcohol misuse: an evidence-based approach. Drug Alcohol Depend 2004;11;74(3):273-9.
66. Chen J, Conigrave KM, Macaskill P, Whitfield JB. Combining CDT and GGT to increase diagnostic accuracy for problem drinking. Alcohol Alcohol 2003;38(6):574-82.
67. Macchia T, Mancinelli R, Gentili S, Ceccanti M, Devito R, Attilia ML, Taggi F. Mitocondrial aspartate aminotransferase isoenzyme: a biochemical marker for the clinical managements of alcoholics? Clin Chim Acta 1997;4;263(1):79-96.
68. Mancinelli R, Ceccanti M, Guiducci MS, Sasso GF, Sebastian G, Attilia ML, Allen JP. Simultaneus liquid chromatography assessment of thiamine, thiamine monophosphate and thiamine diphosphate in human erythrocytes: a study on alcoholics. J Chromatogr B Analyt Technol Biomed Life Sci 2003;15;789(2):355-63.
69. Cook JD. Biochemical markers of alcohol use in pregnant women. Clin Biochem 2003;36(1):9-19.
70. Bearer CF, Stoler JM, Cook JD, Carpenter SJ. Biomarkers of alcohol use in pregnancy. Alcohol Res Health 2004/2005;281:38-43.
71. Sarkola T, Eriksson CJ, Nemela O. MCV and GGT are superior to CDT and HAA in the follow-up of pregnant women with alcohol abuse. Acta Obstet Gynecol Scand 2000;79:359-66.
72. Stoler JM, Huntington KS, Peterson CM. The prenatal detection of significant alcohol exposure with maternal blood markers. J Pediatr 1998;133:346-52.
73. Bearer CF, Jacobson JL, Jacobson SW. Validation of a new biomarker of fetal exposure to alcohol. J Pediatr 2003;143(4):463-9.
74. Chan D, Caprara D, Blanchette P, Klein J, Koren G. Recent developments in meconium and hair testing methods for the confirmation of gestational exposure to alcohol and tobacco use. Clin Biochem 2004;37(6):429-38.
75. Ba A, Seri BV, Aka KJ, Glin L, Tako A. Comparative effects of developmental thiamine deficiencies on the morphometry of the CA3 pyramidal cells. Neurotoxicol Teratol 1999;21(5):579-86.
76. Neuhold LA, Gud QM, Alper J. High-throughput proteomics for alcohol research. Alcohol Clin Exp Res 2004;28:203-10.